ROSSARI BIOTECH Financial Statement Analysis
|
||
|
The Revenues of ROSSARI BIOTECH have increased by 10.55% YoY .
The Earnings Per Share (EPS) of ROSSARI BIOTECH has increased by 4.10 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
ROSSARI BIOTECH Last 5 Annual Financial Results
[BOM: 543213|NSE : ROSSARI]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹1,831 Cr | ₹1,656 Cr | ₹1,483 Cr | ₹709 Cr | ₹600 Cr |
| Expenses | ₹1,587 Cr | ₹1,441 Cr | ₹1,307 Cr | ₹586 Cr | ₹495 Cr |
| Operating Profit (Excl OI) | ₹243 Cr | ₹215 Cr | ₹176 Cr | ₹123 Cr | ₹105 Cr |
| Other Income | ₹14 Cr | ₹14 Cr | ₹19 Cr | ₹9.19 Cr | ₹3.72 Cr |
| Interest | ₹19 Cr | ₹22 Cr | ₹13 Cr | ₹2.99 Cr | ₹3.56 Cr |
| Depreciation | ₹60 Cr | ₹63 Cr | ₹48 Cr | ₹23 Cr | ₹17 Cr |
| Profit Before Tax | ₹178 Cr | ₹144 Cr | ₹136 Cr | ₹107 Cr | ₹88 Cr |
| Profit After Tax | ₹131 Cr | ₹107 Cr | ₹98 Cr | ₹80 Cr | ₹65 Cr |
| Consolidated Net Profit | ₹131 Cr | ₹107 Cr | ₹98 Cr | ₹80 Cr | ₹65 Cr |
| Earnings Per Share (Rs) | ₹24.63 | ₹23.66 | ₹19.45 | ₹17.74 | ₹15.45 |
| PAT Margin (%) | 6.54 | 7.11 | 6.45 | 6.56 | 11.19 |
| ROE(%) | 12.25 | 13.36 | 12.52 | 16.17 | 23.11 |
| ROCE(%) | 16.07 | 18.39 | 18.48 | 24.37 | 28.81 |
| Total Debt/Equity(x) | 0.16 | 0.10 | 0.08 | 0.01 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 3,707.4 Cr |
| Revenue (TTM) | : | ₹ 2,134.4 Cr |
| Net Profit(TTM) | : | ₹ 133.8 Cr |
| EPS (TTM) | : | ₹ 24.1 |
| P/E (TTM) | : | 27.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ROSSARI BIOTECH | -4.6% | -1.4% | -22.9% |
| PIDILITE INDUSTRIES | 6% | -0.8% | -2.4% |
| SRF | -2.3% | -9.7% | 22.9% |
| SOLAR INDUSTRIES INDIA | 5.5% | -9.1% | 44.5% |
| GUJARAT FLUOROCHEMICALS | 1.3% | 5.8% | 9.2% |
| GODREJ INDUSTRIES | -0.8% | -1.4% | 29.6% |
| DEEPAK NITRITE | -1.6% | -8.4% | -38.3% |
| TATA CHEMICALS | -3.3% | 2.6% | -8.3% |
| HIMADRI SPECIALITY CHEMICAL | -3.3% | -7.2% | 3.7% |
ROSSARI BIOTECH Revenues
[BOM: 543213|NSE : ROSSARI]
| Y-o-Y | 10.55 % |
| 5 Yr CAGR | 32.16 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,831 Cr | 10.55 | |
| Mar2024 | ₹1,656 Cr | 11.66 | |
| Mar2023 | ₹1,483 Cr | 109.06 | |
| Mar2022 | ₹709 Cr | 18.21 | |
| Mar2021 | ₹600 Cr | - | |
ROSSARI BIOTECH Operating Profit
[BOM: 543213|NSE : ROSSARI]
| Y-o-Y | 13.29 % |
| 5 Yr CAGR | 23.43 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹243 Cr | 13.29 | |
| Mar2024 | ₹215 Cr | 21.70 | |
| Mar2023 | ₹176 Cr | 43.26 | |
| Mar2022 | ₹123 Cr | 17.48 | |
| Mar2021 | ₹105 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 2.47 % |
| 5 Yr CAGR | -6.60 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 13.28% | 2.47 | |
| Mar2024 | 12.96% | 9.00 | |
| Mar2023 | 11.89% | -31.47 | |
| Mar2022 | 17.35% | -0.57 | |
| Mar2021 | 17.45% | - | |
ROSSARI BIOTECH Profit After Tax
[BOM: 543213|NSE : ROSSARI]
| Y-o-Y | 21.85 % |
| 5 Yr CAGR | 18.96 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹131 Cr | 21.85 | |
| Mar2024 | ₹107 Cr | 9.81 | |
| Mar2023 | ₹98 Cr | 21.76 | |
| Mar2022 | ₹80 Cr | 22.94 | |
| Mar2021 | ₹65 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -8.02 % |
| 5 Yr CAGR | -12.56 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 6.54 % | -8.02 | |
| Mar2024 | 7.11 % | 10.23 | |
| Mar2023 | 6.45 % | -1.68 | |
| Mar2022 | 6.56 % | -41.38 | |
| Mar2021 | 11.19 % | - | |
ROSSARI BIOTECH Earnings Per Share (EPS)
[BOM: 543213|NSE : ROSSARI]
| Y-o-Y | 4.10 % |
| 5 Yr CAGR | 12.37 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹25 | 4.10 | |
| Mar2024 | ₹24 | 21.65 | |
| Mar2023 | ₹19 | 9.64 | |
| Mar2022 | ₹18 | 14.82 | |
| Mar2021 | ₹15 | - | |
ROSSARI BIOTECH Return on Capital Employed (ROCE)
[BOM: 543213|NSE : ROSSARI]
| Y-o-Y | -12.62 % |
| 5 Yr CAGR | -13.58 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 16.07% | -12.62 | |
| Mar2024 | 18.39% | -0.49 | |
| Mar2023 | 18.48% | -24.17 | |
| Mar2022 | 24.37% | -15.41 | |
| Mar2021 | 28.81% | - | |
ROSSARI BIOTECH Share Price vs Sensex
| Current Share Price | : | ₹669.2 |
| Current MarketCap | : | ₹ 3,707.4 Cr |
| Updated EOD on | : | Aug 06,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ROSSARI BIOTECH | -4.6% |
-1.4% |
-22.9% |
| SENSEX | -1.2% |
-3.5% |
-0.5% |
ROSSARI BIOTECH related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE COMMODITIES | -1.3% | -1.4% | 1.9% |
| BSE SMALLCAP | -3.1% | -4.4% | -4.4% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY TOTAL MARKET | -1.7% | -3.7% | -2.6% |
| NIFTY MICROCAP 250 | -3.2% | -3.4% | -5.1% |
You may also like the below Video Courses
FAQ about ROSSARI BIOTECH Financials
How the annual revenues of ROSSARI BIOTECH have changed ?
The Revenues of ROSSARI BIOTECH have increased by 10.55% YoY .
How the Earnings per Share (EPS) of ROSSARI BIOTECH have changed?
The Earnings Per Share (EPS) of ROSSARI BIOTECH has increased by 4.10 % YoY .
Check out Intrinsic Value of Peers of ROSSARI BIOTECH
Compare Stock Analytics of Peers of ROSSARI BIOTECH
PIDILITE INDUSTRIES LTD vs SRF LTD vs SOLAR INDUSTRIES INDIA LTD
GUJARAT FLUOROCHEMICALS LTD vs GODREJ INDUSTRIES LTD vs
PIDILITE INDUSTRIES LTD vs SRF LTD vs SOLAR INDUSTRIES INDIA LTD
GUJARAT FLUOROCHEMICALS LTD vs GODREJ INDUSTRIES LTD vs
